SOTIO Biotech: SOTIO Unveils Promising Preclinical Data on SOT109, a Next-Gen ADC Targeting Cadherin-17 (CDH17) for Colorectal Cancer
SOT109 leverages exatecan-based payload to produce potential best-in-class ADC for validated CDH17 target SOT109 expected to enter a first-in-human Phase 1 clinical trial in 2026 SOTIO ...
Coingape54m
Bitcoin History Rhymes as Analyst Points Out Similarities with $180K BTC Price Target
Bitcoin price targets $180k as historical trends reveal an uptrend formation amid the ongoing bullish movement. Will BTC ...